Does OCRELIZUMAB Cause Multiple sclerosis? 2,609 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,609 reports of Multiple sclerosis have been filed in association with OCRELIZUMAB (OCREVUS). This represents 4.6% of all adverse event reports for OCRELIZUMAB.
2,609
Reports of Multiple sclerosis with OCRELIZUMAB
4.6%
of all OCRELIZUMAB reports
28
Deaths
604
Hospitalizations
How Dangerous Is Multiple sclerosis From OCRELIZUMAB?
Of the 2,609 reports, 28 (1.1%) resulted in death, 604 (23.2%) required hospitalization, and 17 (0.7%) were considered life-threatening.
Is Multiple sclerosis Listed in the Official Label?
Yes, Multiple sclerosis is listed as a known adverse reaction in the official FDA drug label for OCRELIZUMAB.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
Multiple sclerosis relapse (2,326)
What Other Drugs Cause Multiple sclerosis?
DIMETHYL (5,074)
NATALIZUMAB (4,078)
INTERFERON BETA-1A (3,412)
GLATIRAMER (2,596)
DALFAMPRIDINE (2,224)
FINGOLIMOD (2,123)
TERIFLUNOMIDE (1,983)
OFATUMUMAB (1,267)
DIROXIMEL (978)
ADALIMUMAB (614)
Which OCRELIZUMAB Alternatives Have Lower Multiple sclerosis Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE